Intelligence · Clinical Development
Pipeline search results
Programs matching “placebo” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 588 pipeline programs matching "placebo" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Arvisol placebo, Arvisol 150mg
Pari Pharma GmbH
Patients with severe Alcohol Use Disorder (according to DSM 5) at entry of a scheduled inpatient alcohol cessation attempt
1 trial -
BFB759, Placebo
Blue Earth Diagnostics Ireland Ltd
Atopic dermatitis
1 trial -
BIIB122, Placebo to BIIB122
Denali Therapeutics
Parkinson’s disease
1 trial -
BMS-945429 Placebo
CSL Behring GmbH
Rheumatoid Arthritis
1 trial -
Bexarotene/NBUVB vs placebo NBUVB
LIGAND PHARMACEUTICALS INC
Psoriasis
1 trial -
Budenofalk 4 mg Zäpfchen, placebo to test
Dr. Falk Pharma GmbH
Acute radiation proctitis symptoms in male patients aged 18 years or older with prostate carcinoma
1 trial -
CRD-4730, CRD-4730 matching placebo
Lacuna Pharma Pty Ltd
Catecholaminergic Polymorphic Ventricular Tachycardia
1 trial -
Crofelemer Placebo Powder for Oral Solution
Lacuna Pharma Pty Ltd
Microvillous Inclusion Disease (MVID)
1 trial -
DASATINIB, Placebo
The George Institute
Asymptomatic patients with recent HIV-1 infection
1 trial -
DNTH103, Matching placebo to DNTH103
Dianthus Therapeutics, Inc. /DE/
Multifocal Motor Neuropathy
1 trial -
EB01 Cream Placebo
Edesa Biotech
Allergic Contact Dermatitis
1 trial -
EDP-938, EDP-938 Placebo tablets
ENANTA PHARMACEUTICALS INC
Respiratory syncytial virus (RSV)
1 trial -
Enpatoran Placebo, Enpatoran
Merck Sharp and Dohme
Systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE)
1 trial -
Fasedienol Nasal Spray - Placebo Nasal Spray
Vistagen Therapeutics
Social Anxiety Disorder
1 trial -
Film-coated placebo to match estetrol monohydrate (E4) 20mg tablet
Estetra SPRL
postmenopausal women with vasomotor menopausal symptoms
1 trial -
Flortaucipir, Placebo to match LY3372689
Eli Lilly Co.
Alzheimer Disease
1 trial -
Frexalimab, Matched Placebo for Test
Sanofi-aventis Healthcare Pty Ltd
Systemic lupus erythematosus
1 trial -
GS-4321 PLACEBO
Gilead Sciences Pty Limited
Chronic Hepatitis Delta.
1 trial -
IDOR-1117-2520 matching placebo
Lacuna Pharma Pty Ltd
Moderate to severe chronic plaque psoriasis
1 trial -
ILT-101 liquide, Placebo of ILT-101
Pari Pharma GmbH
Autism Spectrum disorder ASD
1 trial -
INCB000928, Placebo
Incyte
Fibrodysplasia Ossificans Progressiva
1 trial -
IPN10200, IPN10200 placebo
Ipsen
Episodic Migraine Chronic Migraine
1 trial -
ISIS 301012 or Placebo
IONIS PHARMACEUTICALS INC
Hypercholesterolemia, Familial
1 trial -
ISIS 301012 or Placebo
IONIS PHARMACEUTICALS INC
Hypercholesterolemia
2 trials
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.